Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Insulin Drugs Market 2022 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, Human Insulin), By Application (Type 2 Diabete, Type 1 Diabetes, Gestational Diabetes), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) And By Region, Opportunities And Strategies – Global Forecast To 2031

Insulin Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change

Starting Price : $5000.00 $3500.00 | Pages : 270 | Published : June 2022 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Insulin Drugs Market Definition

The insulin drugs market consists of manufacturers’ sales of insulin drugs and types of Insulin by entities (organizations, sole traders and partnerships) which are used to treat diabetes. Insulin is a medication prescribed to treat type 1 diabetes and type 2 diabetes mellitus.

There are several types, preparations, and dosage amount of insulin. Insulin is a hormone that is produced naturally in our bodies. Its main role is to allow cells throughout the body to uptake glucose (sugar) and convert it into a form that can be used by these cells for energy. Insulin is available as synthetic human insulin that is laboratory grown to mimic the human insulin) and insulin analogues that are genetically modified human insulin. Insulin is most commonly administered subcutaneously.

Book your 30 minutes free consultation with our research experts

Contact Us

Insulin Drugs Market Size

The global insulin drugs market size reached a value of nearly $28,951.9 million in 2021, having grown at a compound annual growth rate (CAGR) of 3.1% since 2016. The global insulin drugs market size is expected to grow from $28,951.9 million in 2021 to $39,370.2 million in 2026 at a rate of 6.3%. The global insulin drugs market size is then expected to grow at a CAGR of 5.7% from 2026 and reach $51,973.2 million in 2031.    

Growth in the historic period resulted from an increase in diabetes prevalence, emerging markets growth, increased geriatric population and growth in insulin analogues.

Going forward, the increase in disease burden, government initiatives and increase in R&D and collaborations will drive the growth. Factors that could hinder the growth of the market in the future include availability of alternative treatments and natural remedies and high costs.

Insulin Drugs Market Drivers

The key drivers of the insulin drugs market include:

Increase in Disease Burden

Rising numbers of diabetic cases will continue to be a driver of this market during the forecast period. According to the International Diabetes Federation (IDF), in 2021, 537 million adults aged in between 20-79 are living with diabetes (1 in 10 are suffering with diabetes) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Thus the need for insulin drugs is set to rise steadily during the forecast period. In emerging countries such as India, around 77 million people are diabetic, and this number is expected to rise to 134 million by 2045.  In China, by 2045, it is predicted that 174 million people will be diagnosed with diabetes.

Insulin Drugs Market Restraints

The key restraints on the insulin drugs market include:

Availability of Alternative Treatments and Natural Remedies

Companies in the market are facing rising competition from alternative treatments. New drugs are likely to increase the percentages of patients treated with oral medication that do not require the use of a device. With growing awareness and research on diabetes, other new methods of treatments are being developed in various parts of the world. Treatments in the fields of homeopathy, ayurveda, yoga, acupuncture, gene and cell-replacement therapy are gaining popularity. Increases in preferences for alternative treatments will slowly replace traditional insulin, thereby affecting the growth of the market in the forecast period. Some people with diabetes also use complementary and alternative therapies (CAM). These therapies aim to treat the body and the mind, which include herbs, supplements, diet, exercise and relaxation techniques.

Insulin Drugs Market Trends

Major trends influencing the insulin drugs market include:

Rise In Product Launches And Approvals

The Insulin drugs market is witnessing a rise in new product launches. Major companies operating in the market are increasingly launching new products, either to increase their product offerings or to gain competitive advantage. New product launch is a process of introducing a newer advanced product offering in the market.  The introduction of new product into the market can increase revenue streams, drive momentum in the brand image, and thereby increase the company’s market share. For instance, in August 2020, the Indian biopharmaceutical company, Biocon Biologics, and Mylan, a US-based pharmaceutical company, launched Semglee in the USA. It is a new insulin glargine injection that controls high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. The product received approval in July 2021, from the US FDA. Similarly in 2019, a US-based pharmaceutical company, Eli Lilly, introduced a generic version of Humalog in the US. In addition, in 2018, Sanofi India, a pharmaceutical company, launched Toujeo, new diabetes treatment insulin in India.

Adoption Of Advanced Technologies

Companies in the insulin drugs market are investing in technologies such as artificial intelligence (AI), smart-device integration, and the usage of 3D-printed organs for the development of insulin drugs. Adoption of advanced technologies saves time and reduces research and development costs. AI is being used by pharmaceutical companies to read and review scientific articles, summarize them, and analyze large sets of chemical and biological data to identify better drugs dosage. For example, Sanofi, a French pharmaceutical company, uses AI to automate medical literature reviews on type 2 diabetes. With the help of AI, the company reduced the review time from 13 minutes per paper to around one second per paper. Similarly, device integration of insulin enables the user to effectively keep track of drug delivery. In January 2021, Insulet Corporation launched its smart connected drug delivery device Omnipod Dash in Canada. Omnipod Dash is an insulin management system that allows users to wirelessly control the pods to deliver and track their insulin therapy. In addition, 3D-printed organs mimic the human body to test new drugs. For instance, in June 2021, Readily3D SA, a Switzerland-based volumetric 3D bioprinter manufacturer, started to develop a 3D bio-printed mini pancreas for efficient diabetes drug testing.

Opportunities And Recommendations In The Insulin Drugs Market

Opportunities –The top opportunities in the insulin drugs market segmented by product type will arise in the basal or long-acting insulins segment, which will gain $4,514.4 million of global annual sales by 2026. The top opportunities in the insulin drugs market segmented by source type will arise in the insulin analogs segment, which will gain $8,380.5 million of global annual sales by 2026. The top opportunities in segment by application will arise in the type 2 segment, which will gain $6,861.0 million of global annual sales by 2026. The top opportunities in segment by drug classification will arise in the branded drugs segment, which will gain $7,641.0 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the retail pharmacies segment, which will gain $5,494.2 million of global annual sales by 2026. The insulin drugs market size will gain the most in the USA at $3,770.4 million.

Recommendations –To take advantage of the opportunities, The Business Research Company recommends the insulin drugs companies to focus on adoption of advanced technologies, launch new, innovative products, focus on strategic partnerships, expand into developing countries, set up authorized distributors and sales representatives, leverage online pharmacies, provide competitively priced offerings, focus on securing long-term supply contracts with healthcare institutions, offer value-based pricing, focus on increasing awareness about insulin drugs, leverage social media use to maximize reach and focus on the ageing population.

Insulin Drugs Market Segmentation

Insulin drugs market is segmented by product type, source type, application, drug classification, distribution channel, and geography.
By Product Type–
The insulin drugs market is segmented by product type into
    • a) Basal Or Long-Acting Insulins
    • b) Bolus Or Fast-Acting Insulins
    • c) Pre-Mixed Insulins
    • d) Intermediate And Short Acting Insulins
The basal or long-acting insulins market was the largest segment of the insulin drugs market segmented by product type, accounting for 43.8% of the total in 2021. Going forward, the pre-mixed market is expected to be the fastest growing segment in the insulin drugs market segmented by product type, at a CAGR of 6.5% during 2021-2026.
By Source Type–
The insulin drugs market is segmented by source type into
    • a) Insulin Analogs
    • b) Human Insulin
The insulin analogs market was the largest segment of the insulin drugs market segmented by source type, accounting for 80.4% of the total in 2021. Going forward, the insulin analogs market is expected to be the fastest growing segment in the insulin drugs market segmented by source type at a CAGR of 6.35% during 2021-2026.
By Application –
The insulin drugs market is segmented by application into
    • a) Type 2 Diabetes
    • b) Type 1 Diabetes
    • c) Gestational Diabetes
The type 2 market was the largest segment of the insulin drugs market segmented by application, accounting for 61.2% of the total in 2021. Going forward, the type 2 market is expected to be the fastest growing segment in the insulin drugs market segmented by application, at a CAGR of 6.8% during 2021-2026.
By Drug Classification –
The insulin drugs market is segmented by drug classification into
    • a) Branded Drugs
    • b) Generic Drugs
The branded drugs market was the largest segment of the insulin drugs market segmented by drug classification, accounting for 79.6% of the total in 2021. Going forward, the generic drugs market is expected to be the fastest growing segment in the insulin drugs market segmented by drug classification, at a CAGR of 8.0% during 2021-2026.
By Distribution Channel –
The insulin drugs market is segmented by distribution channel into
    • a) Hospital Pharmacies
    • b) Retail Pharmacies
    • c) Online
The retail pharmacies market was the largest segment of the insulin drugs market segmented by distribution channel, accounting for 50.8% of the total in 2021. Going forward, the online market is expected to be the fastest growing segment in the insulin drugs market segmented by distribution channel, at a CAGR of 7.3% during 2021-2026.
By Geography- The insulin drugs market is segmented by geography into
    • o Asia Pacific
      • •  China
      • •  Japan
      • •  India
      • •  Australia
      • •  Indonesia
      • •  South Korea
      • o North America
      • • USA
      o South America
      • • Brazil 
      o Western Europe
      • • UK 
      • • Germany 
      • • France 
      o Eastern Europe
      • • Russia 
      o Middle East
      o Africa
North America was the largest region in the global insulin drugs market, accounting for 42.0% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the global insulin drugs market will be Asia Pacific, and, Eastern Europe where growth will be at CAGRs of 8.7% and 7.1% respectively. These will be followed by North America, and Middle East, where the markets are expected to grow at CAGRs of 5.9% and 4.7% respectively.

Insulin Drugs Market Competitive Landscape

Major Competitors are:

  • Bioton
  • Wockhardt Ltd
  • Julphar
  • Tonghua Dongbao Pharmaceutical
  • AstraZeneca

    • Other Competitors Include:

  • Mehar healthcare
  • GE Healthcare
  • Philips Healthcare India
  • Shandong WeiGao Group Medical Polymer Company Limited
  • Yuwell Medical Equipment & Supply Co
  • Terumo
  • NIPRO
  • Olympus Medical Systems
  • Hitachi Medico
  • Nihon Kohden
  • Fukuda Denshi
  • Emperra GmbH E-Health Technologies
  • DIABNEXT™
  • Berlin-Chemie AG
  • Ypsomed Holding AG
  • Patients Pending Ltd
  • Dexcom
  • Johnson and Johnson
  • Medtronic
  • Abbott Laboratories
  • Acon Laboratories
  • Ypsomed AG
  • Tandem Diabetes Care, Inc.
  • Becton
  • Dickinson
  • Insulet Corporation
  • AJA Pharma
  • SEDICO Pharmaceutical Company
  • Pfizer

      • Table Of Contents

      1. Insulin Drugs Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1.1. Segmentation By Geography

      6.1.2. Segmentation By Product Type

      6.1.3. Segmentation By Source Type

      6.1.4. Segmentation By Application

      6.1.5. Segmentation By Drug Classification

      6.1.6. Segmentation By Distribution Channel

      7. Insulin Drugs Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Product Type

      7.2.1. Basal Or Long-Acting Insulins

      7.2.2. Bolus Or Fast-Acting Insulins

      7.2.3. Pre Mixed Insulins

      7.2.4. Intermediate And Short Acting Insulins

      7.3. By Source Type

      7.3.1. Insulin Analogs

      7.3.2. Human Insulin

      7.4. Market Segmentation By Application

      7.4.1. Type 2 Diabetes

      7.4.2. Type 1 Diabetes

      7.4.3. Gestational Diabetes

      7.5. Market Segmentation By Drug Classification

      7.5.1. Branded Drugs

      7.5.2. Generic Drugs

      7.6. Market Segmentation By Distribution Channel

      7.6.1. Hospital Pharmacies

      7.6.2. Retail Pharmacies

      7.6.3. Online

      8. Insulin Drugs Market Trends And Strategies

      8.1. Rise In Product Launches And Approvals

      8.2. Mergers And Acquisitions

      8.3. Strategic Partnerships

      8.4. Robust Research And Development

      8.5. Adoption Of Advanced Technologies

      9. Impact Of COVID-19 On The Insulin Drugs Market

      9.1. Introduction

      9.2. Impact On Diabetic Patients

      9.3. Impact On Insulin Intake By Patients

      9.4. Severe Impact On Low- And Middle- Income Countries

      9.5. Impact On Companies

      10. Global Insulin Drugs Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)

      10.2.1. Drivers Of The Market 2016 – 2021

      10.2.2. Increase in Diabetes Prevalence

      10.2.3. Emerging Markets Growth

      10.2.4. Restraints On The Market 2016 – 2021

      10.2.5. Preference for Oral Treatment

      10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      10.3.1. Drivers Of The Market 2021 – 2026

      10.3.2. Increase in Disease Burden

      10.3.3. Government Initiatives

      10.3.4. Increase in R&D and Collaborations

      10.3.5. Restraints On The Market 2021 – 2026

      10.3.6. Availability of Alternative Treatments

      11. Global Insulin Drugs Market Segmentation

      11.1. Global Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.2. Global Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.3. Global Insulin Drugs Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.4. Global Insulin Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      11.5. Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12. Insulin Drugs Market, Regional And Country Analysis

      12.1. Global Insulin Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      12.2. Global Insulin Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13. Asia-Pacific Insulin Drugs Market

      13.1. Asia-Pacific Insulin Drugs Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Background Information

      13.1.4. Government Initiatives

      13.1.5. Regulations

      13.1.6. Regulatory Bodies

      13.1.7. Major Associations

      13.1.8. Taxes Levied

      13.1.9. Corporate Tax Structure

      13.1.10. Investments

      13.1.11. Major Companies

      13.2. Asia-Pacific Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.3. Asia-Pacific Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.4. Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.5. Asia-Pacific Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.6. Asia-Pacific Insulin Drugs Market: Country Analysis

      13.7. China Insulin Drugs Market

      13.8. China Insulin Drugs Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Background Information

      13.8.4. Government Initiatives

      13.8.5. Regulations

      13.8.6. Regulatory Bodies

      13.8.7. Major Associations

      13.8.8. Taxes Levied

      13.8.9. Corporate Tax Structure

      13.8.10. Investments

      13.8.11. Major Companies

      13.9. China Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.10. China Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.11. China Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.12. China Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.13. India Insulin Drugs Market

      13.14. India Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.15. India Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.16. India Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.17. India Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.18. Japan Insulin Drugs Market

      13.19. Japan Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.20. Japan Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.21. Japan Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.22. Japan Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.23. Australia Insulin Drugs Market

      13.24. Australia Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.25. Australia Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.26. Australia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.27. Australia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.28. Indonesia Insulin Drugs Market

      13.29. Indonesia Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.30. Indonesia Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.31. Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.32. Indonesia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.33. South Korea Insulin Drugs Market

      13.34. South Korea Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      13.35. South Korea Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      13.36. South Korea Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      13.37. South Korea Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14. Western Europe Insulin Drugs Market

      14.1. Western Europe Insulin Drugs Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Background Information

      14.1.4. Government Initiatives

      14.1.5. Regulations

      14.1.6. Regulatory Bodies

      14.1.7. Major Associations

      14.1.8. Taxes Levied

      14.1.9. Corporate Tax Structure

      14.1.10. Investments

      14.1.11. Major Companies

      14.2. Western Europe Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.3. Western Europe Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.4. Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.5. Western Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.6. Western Europe Insulin Drugs Market: Country Analysis

      14.7. UK Insulin Drugs Market

      14.8. UK Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.9. UK Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.10. UK Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.11. UK Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.12. Germany Insulin Drugs Market

      14.13. Germany Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.14. Germany Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.15. Germany Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.16. Germany Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.17. France Insulin Drugs Market

      14.18. France Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      14.19. France Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      14.20. France Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      14.21. France Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15. Eastern Europe Insulin Drugs Market

      15.1. Eastern Europe Insulin Drugs Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Background Information

      15.1.4. Government Initiatives

      15.1.5. Regulations

      15.1.6. Regulatory Bodies

      15.1.7. Major Associations

      15.1.8. Taxes Levied

      15.1.9. Corporate Tax Structure

      15.1.10. Investments

      15.1.11. Major Companies

      15.2. Eastern Europe Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.3. Eastern Europe Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.4. Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.5. Eastern Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.6. Eastern Europe Insulin Drugs Market: Country Analysis

      15.7. Russia Insulin Drugs Market

      15.8. Russia Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      15.9. Russia Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      15.10. Russia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      15.11. Russia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16. North America Insulin Drugs Market

      16.1. North America Insulin Drugs Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Background Information

      16.1.4. Government Initiatives

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.3. North America Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.4. North America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.5. North America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.6. North America Insulin Drugs Market: Country Analysis

      16.7. USA Insulin Drugs Market

      16.8. USA Insulin Drugs Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. Background Information

      16.8.4. Government Initiatives

      16.8.5. Regulations

      16.8.6. Regulatory Bodies

      16.8.7. Major Associations

      16.8.8. Taxes Levied

      16.8.9. Corporate Tax Structure

      16.8.10. Investments

      16.8.11. Major Companies

      16.9. USA Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      16.10. USA Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      16.11. USA Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      16.12. USA Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17. South America Insulin Drugs Market

      17.1. South America Insulin Drugs Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Background Information

      17.1.4. Government Initiatives

      17.1.5. Regulations

      17.1.6. Regulatory Bodies

      17.1.7. Major Associations

      17.1.8. Taxes Levied

      17.1.9. Corporate Tax Structure

      17.1.10. Investments

      17.1.11. Major Companies

      17.2. South America Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.3. South America Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.4. South America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.5. South America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.6. South America Insulin Drugs Market: Country Analysis

      17.7. Brazil Insulin Drugs Market

      17.8. Brazil Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      17.9. Brazil Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      17.10. Brazil Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      17.11. Brazil Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18. Middle East Insulin Drugs Market

      18.1. Middle East Insulin Drugs Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Background Information

      18.1.4. Government Initiatives

      18.1.5. Regulations

      18.1.6. Regulatory Bodies

      18.1.7. Major Associations

      18.1.8. Taxes Levied

      18.1.9. Corporate Tax Structure

      18.1.10. Investments

      18.1.11. Major Companies

      18.2. Middle East Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      18.3. Middle East Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      18.4. Middle East Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      18.5. Middle East Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19. Africa Insulin Drugs Market

      19.1. Africa Insulin Drugs Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Major Associations

      19.1.8. Taxes Levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Insulin Drugs Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

      19.3. Africa Insulin Drugs Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

      19.4. Africa Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      19.5. Africa Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

      20. Global Insulin Drugs Market Competitive Landscape And Company Profiles

      20.1. Company Profiles

      20.2. Novo Nordisk A/S

      20.2.1. Company Overview

      20.2.2. Products And Services.

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Sanofi S.A

      20.3.1. Company Overview

      20.3.2. Products And Services.

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Eli Lilly And Company

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Biocon Limited

      20.5.1. Company Overview

      20.5.2. Products And Services.

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Gan & Lee Pharmaceuticals

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Insulin Drugs Market Pipeline Analysis

      22. Key Mergers And Acquisitions In The Insulin Drugs Market

      22.1. Eli Lilly Agreement with AJA Pharma

      22.2. Eli Lilly and Company Acquired Protomer Technologies

      22.3. Vertex Pharmaceuticals Acquired Semma Therapeutics

      22.4. Novo Nordisk Acquired Ziylo

      23. Insulin Drugs Market Opportunities And Strategies

      23.1. Global Insulin Drugs Market In 2026 – Countries Offering Most New Opportunities

      23.2. Global Insulin Drugs Market In 2026 – Segments Offering Most New Opportunities

      23.3. Global Insulin Drugs Market In 2026 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Insulin Drugs Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      26. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 2: Global Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 3: Global Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 4: Global Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 5: Global Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 6: Global Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 7: Global Insulin Drugs Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 8: Global Insulin Drugs Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 9: Global Insulin Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 10: Global Insulin Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 11: Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 12: Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 13: Global Insulin Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 14: Global Insulin Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 15: Global Insulin Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 16: Global Insulin Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 17: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 18:  Asia Pacific Population By Age Group, 2015-2025, Thousands
    • Table 19: Asia Pacific Diabetes Prevalence Rate, 2015-2019,%
    • Table 20: Asia-Pacific Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 21: Asia-Pacific Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 22: Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 23: Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 24: Asia-Pacific Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 25: Asia-Pacific Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 26: China GDP Per Capita, 2015-2020, $
    • Table 27:  China Population By Age Group, 2015-2025, Thousands
    • Table 28: China Diabetes Prevalence Rate, 2015-2019,%
    • Table 29: China Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 30: China Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 31: China Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 32: China Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 33: China Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 34: China Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 35: India Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 36: India Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 37: India Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 38: India Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 39: India Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 40: India Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 41: Japan Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 42: Japan Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 43: Japan Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 44: Japan Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 45: Japan Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 46: Japan Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 47: Australia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 48: Australia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 49: Australia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 50: Australia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 51: Australia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 52: Australia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 53: Indonesia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 54: Indonesia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 55: Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 56: Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 57: Indonesia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 58: Indonesia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 59: South Korea Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 60: South Korea Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 61: South Korea Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 62: South Korea Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 63: South Korea Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 64: South Korea Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 65: Western Europe GDP Per Capita, 2015-2020, $
    • Table 66:  Western Europe Population By Age Group, 2015-2025, Thousands
    • Table 67: Western Europe Diabetes Prevalence Rate, 2015-2019,%
    • Table 68: Western Europe Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 69: Western Europe Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 70: Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 71: Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 72: Western Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 73: Western Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 74: UK Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 75: UK Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 76: UK Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 77: UK Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 78: UK Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 79: UK Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 80: Germany Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 81: Germany Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 82: Germany Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 83: Germany Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 84: Germany Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 85: Germany Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 86: France Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 87: France Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 88: France Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 89: France Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 90: France Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 91: France Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 92: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 93:  Eastern Europe Population By Age Group, 2015-2025, Thousands
    • Table 94: Eastern Europe Diabetes Prevalence Rate, 2015-2019,%
    • Table 95: Eastern Europe Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 96: Eastern Europe Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 97: Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 98: Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 99: Eastern Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 100: Eastern Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 101: Russia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 102: Russia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 103: Russia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 104: Russia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 105: Russia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 106: Russia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 107: North America GDP Per Capita, 2015-2020, $
    • Table 108:  North America Population By Age Group, 2015-2025, Thousands
    • Table 109: North America Diabetes Prevalence Rate, 2015-2019,%
    • Table 110: North America Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 111: North America Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 112: North America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 113: North America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 114: North America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 115: North America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 116: USA GDP Per Capita, 2015-2020, $
    • Table 117:  USA Population By Age Group, 2015-2025, Thousands
    • Table 118: USA Diabetes Prevalence Rate, 2015-2019,%
    • Table 119: USA Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 120: USA Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 121: USA Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 122: USA Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 123: USA Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 124: USA Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 125: South America GDP Per Capita, 2015-2020, $
    • Table 126:  South America Population By Age Group, 2015-2025, Thousands
    • Table 127: South America Diabetes Prevalence Rate, 2015-2019,%
    • Table 128: South America Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 129: South America Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 130: South America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 131: South America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 132: South America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 133: South America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 134: Brazil Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 135: Brazil Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 136: Brazil Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 137: Brazil Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 138: Brazil Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 139: Brazil Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 140: Middle East GDP Per Capita, 2015-2020, $
    • Table 141:  Middle East Population By Age Group, 2015-2025, Thousands
    • Table 142: Middle East Diabetes Prevalence Rate, 2015-2019,%
    • Table 143: Middle East Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 144: Middle East Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 145: Middle East Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 146: Middle East Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 147: Middle East Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 148: Middle East Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 149: Africa GDP Per Capita, 2015-2020, $
    • Table 150:  Africa Population By Age Group, 2015-2025, Thousands
    • Table 151: Africa Diabetes Prevalence Rate, 2015-2019,%
    • Table 152: Africa Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Table 153: Africa Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Table 154: Africa Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 155: Africa Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 156: Africa Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Table 157: Africa Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
    • Table 158: Global Insulin Drugs, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 159: Novo Nordisk – Financial Performance, $ Billion
    • Table 160: Sanofi – Financial Performance, $ Billion
    • Table 161: Eli Lilly– Financial Performance, $ Billion
    • Table 162: Biocon– Financial Performance, $ Billion
    • Table 163: Gan & Lee– Financial Performance, $ Billion
    • Table 164: Global Insulin Drugs Market, Pipeline Analysis
    • Table 165: Global Insulin Drugs Market Size Gain ($ Million), 2021 – 2026, By Country
    • Table 166: Global Insulin Drugs Market Size Gain ($ Million), Segmentation By Product Type, 2021 – 2026
    • Table 167: Global Insulin Drugs Market Size Gain ($ Million), Segmentation By Source Type, 2021 – 2026
    • Table 168: Global Insulin Drugs Market Size Gain ($ Million), Segmentation By Application, 2021 – 2026
    • Table 169: Global Insulin Drugs Market Size Gain ($ Million), Segmentation By Drug Classification, 2021 – 2026
    • Table 170: Global Insulin Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026
    • Table 171: Insulin Drugs - Market Data Sources

    List Of Figures

      Figure 1: Global Insulin Drugs Market Segmentation By Product Type
    • Figure 2: Global Insulin Drugs Market Segmentation By Source Type
    • Figure 3: Global Insulin Drugs Market Segmentation By Application
    • Figure 4: Global Insulin Drugs Market Segmentation By Drug Classification
    • Figure 5: Global Insulin Drugs Market Segmentation By Distribution Channel
    • Figure 6: Global Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 7: Global Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 8: Global Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 9: Global Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 10: Global Insulin Drugs Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 11: Global Insulin Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 12: Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 13: Global Insulin Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 14: Global Insulin Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 15: Asia-Pacific Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 16: Asia-Pacific Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 17: Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 18: Asia-Pacific Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 19: China Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 20: China Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 21: China Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 22: China Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 23: India Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 24: India Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 25: India Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 26: India Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 27: Japan Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 28: Japan Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 29: Japan Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 30: Japan Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 31: Australia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 32: Australia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 33: Australia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 34: Australia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 35: Indonesia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 36: Indonesia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 37: Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 38: Indonesia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 39: South Korea Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 40: South Korea Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 41: South Korea Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 42: South Korea Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 43: Western Europe Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 44: Western Europe Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 45: Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 46: Western Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 47: UK Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 48: UK Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 49: UK Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 50: UK Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 51: Germany Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 52: Germany Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 53: Germany Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 54: Germany Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 55: France Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 56: France Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 57: France Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 58: France Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 59: Eastern Europe Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 60: Eastern Europe Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 61: Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 62: Eastern Europe Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 63: Russia Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 64: Russia Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 65: Russia Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 66: Russia Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 67: North America Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 68: North America Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 69: North America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 70: North America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 71: USA Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 72: USA Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 73: USA Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 74: USA Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 75: South America Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 76: South America Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 77: South America Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 78: South America Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 79: Brazil Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 80: Brazil Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 81: Brazil Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 82: Brazil Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 83: Middle East Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 84: Middle East Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 85: Middle East Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 86: Middle East Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 87: Africa Insulin Drugs Market, Historic, 2016 – 2021, $ Million
    • Figure 88: Africa Insulin Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
    • Figure 89: Africa Insulin Drugs Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 90: Africa Insulin Drugs Market, Segmentation By Source Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
    • Figure 91: Global Insulin Drugs, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 92: Novo Nordisk – Financial Performance, $ Billion
    • Figure 93: Sanofi– Financial Performance, $ Billion
    • Figure 94: Eli Lilly– Financial Performance, $ Billion
    • Figure 95: Biocon– Financial Performance, $ Billion
    • Figure 96: Gan & Lee– Financial Performance, $ Billion

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Compression Therapy Market Overview In 2022?

    Read More

    The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

    Read More

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    HIV Drugs Global Market Report 2024 – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types), By Administration (Oral, Parenteral), By Application (Hospital Pharmacies, Retail Pharmacies, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Antidepressants Global Market Report 2024 – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)), By Drug Class (Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants), By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder) – Market Size, Trends, And Global Forecast 2024-2033

    View Report